Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03611400 · ClinicalTrials.gov registry record · NA
The Effect of Probiotic Intake on Intestinal Permeability in Healthy Adults
A NA study of Intestinal Barrier Function, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 1
- Study location
NCT03611400 is a NA study of Intestinal Barrier Function that has completed, run by University of Florida. The registered enrollment target is 39 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03611400, a NA study of Intestinal Barrier Function, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
In this double blind, crossover study participants will take a placebo for 3 weeks each. Gut permeability will be assessed weekly using food-grade sugar molecules. On the second week, participants will take aspirin, which will make their intestine permeable to the sugars. Participants will be asked to provide urine and stool samples to assess gut permeability and microbial communities. No change in permeability to the small sugar probes is anticipated with the probiotic.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Probiotic
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2018-08-22 |
| Est. Completion | 2019-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03611400
The ClinicalTrials.gov registry entry for NCT03611400 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intestinal Barrier Function appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03611400 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03611400 about?
NCT03611400 is a clinical study titled "The Effect of Probiotic Intake on Intestinal Permeability in Healthy Adults". In this double blind, crossover study participants will take a placebo for 3 weeks each. Gut permeability will be assessed weekly using food-grade sugar molecules. On the second week, participants will take aspirin, which will make their intestine permeable to the sugars. Participants will be asked ...
What is the current status of trial NCT03611400?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2018-08-22. Estimated completion is 2019-04-15.
What conditions does trial NCT03611400 study?
This clinical trial studies the following conditions: Intestinal Barrier Function.
What interventions are being tested in trial NCT03611400?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03611400?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03611400 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.